Last reviewed · How we verify
Weekly Paclitaxel and Carboplatin — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Weekly Paclitaxel and Carboplatin (Weekly Paclitaxel and Carboplatin) — Hospices Civils de Lyon.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Weekly Paclitaxel and Carboplatin TARGET | Weekly Paclitaxel and Carboplatin | Hospices Civils de Lyon | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Weekly Paclitaxel and Carboplatin CI watch — RSS
- Weekly Paclitaxel and Carboplatin CI watch — Atom
- Weekly Paclitaxel and Carboplatin CI watch — JSON
- Weekly Paclitaxel and Carboplatin alone — RSS
Cite this brief
Drug Landscape (2026). Weekly Paclitaxel and Carboplatin — Competitive Intelligence Brief. https://druglandscape.com/ci/weekly-paclitaxel-and-carboplatin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab